Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 1.27% | 142.23 | 0.7% | $1094.25m | |
| PFE | Pfizer Inc. | 0.70% | 43.81 | 0.9% | $892.61m | |
| MRK | Merck & Co., Inc. | -0.76% | 84.72 | 0.6% | $748.60m | |
| BMY | Bristol-Myers Squibb Company | 0.94% | 49.07 | 1.4% | $533.89m | |
| LLY | Eli Lilly and Company | 0.57% | 115.89 | 1.0% | $486.49m | |
| ABBV | AbbVie, Inc. | 1.55% | 78.81 | 2.2% | $357.28m | |
| NVS | Novartis AG Sponsored ADR | 0.65% | 92.51 | 0.2% | $199.25m | |
| AZN | AstraZeneca PLC Sponsored ADR | 0.31% | 41.81 | 1.2% | $117.75m | |
| GSK | GlaxoSmithKline plc Sponsored ADR | -0.72% | 40.71 | 0.2% | $89.35m | |
| SNY | Sanofi Sponsored ADR | 0.02% | 44.09 | 0.2% | $87.18m | |
| NVO | Novo Nordisk A/S Sponsored ADR Class B | -2.44% | 51.14 | 0.1% | $77.06m | |
| LCI | Lannett Company, Inc. | 0.00% | 5.68 | 36.6% | $4.60m | |
| AKTX | Akari Therapeutics Plc Sponsored ADR | -5.02% | 2.08 | 1.6% | $0.42m | |
| EPIX | ESSA Pharma Inc | 3.27% | 2.38 | 0.1% | $0.01m |
Company Profile
Menlo Therapeutics Inc. operates as biopharmaceutical company which is focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. The company was founded in October, 2011 and is headquartered in Redwood City, CA.